185 related articles for article (PubMed ID: 26096702)
1. Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma.
Yang JD; Campion MB; Liu MC; Chaiteerakij R; Giama NH; Ahmed Mohammed H; Zhang X; Hu C; Campion VL; Jen J; Venkatesh SK; Halling KC; Kipp BR; Roberts LR
Hepatology; 2016 Jan; 63(1):148-58. PubMed ID: 26096702
[TBL] [Abstract][Full Text] [Related]
2. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
4. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.
Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B
BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.
Cheng Q; Feng F; Zhu L; Zheng Y; Luo X; Liu C; Yi B; Jiang X
Sci Rep; 2015 Nov; 5():16103. PubMed ID: 26534789
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Xu H; Wang Z
BMC Cancer; 2015 Mar; 15():202. PubMed ID: 25880692
[TBL] [Abstract][Full Text] [Related]
8. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand.
Woradet S; Promthet S; Songserm N; Parkin DM
Asian Pac J Cancer Prev; 2013; 14(3):1623-7. PubMed ID: 23679246
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
[TBL] [Abstract][Full Text] [Related]
11. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer.
Nakamura S; Yagata H; Ohno S; Yamaguchi H; Iwata H; Tsunoda N; Ito Y; Tokudome N; Toi M; Kuroi K; Suzuki E
Breast Cancer; 2010 Jul; 17(3):199-204. PubMed ID: 19649686
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.
Okabe H; Tsunoda S; Hosogi H; Hisamori S; Tanaka E; Tanaka S; Sakai Y
Ann Surg Oncol; 2015 Nov; 22(12):3954-61. PubMed ID: 25777087
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer.
Bitting RL; Healy P; Halabi S; George DJ; Goodin M; Armstrong AJ
Urol Oncol; 2015 Mar; 33(3):110.e1-9. PubMed ID: 25595577
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma.
Boonla C; Wongkham S; Sheehan JK; Wongkham C; Bhudhisawasdi V; Tepsiri N; Pairojkul C
Cancer; 2003 Oct; 98(7):1438-43. PubMed ID: 14508831
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
16. Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.
Thalgott M; Rack B; Eiber M; Souvatzoglou M; Heck MM; Kronester C; Andergassen U; Kehl V; Krause BJ; Gschwend JE; Retz M; Nawroth R
BMC Cancer; 2015 Jun; 15():458. PubMed ID: 26051431
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
[TBL] [Abstract][Full Text] [Related]
18. Exploring Circulating Tumor Cells in Cholangiocarcinoma Using a Novel Glycosaminoglycan Probe on a Microfluidic Platform.
Gopinathan P; Chiang NJ; Bandaru A; Sinha A; Huang WY; Hung SC; Shan YS; Lee GB
Adv Healthc Mater; 2020 May; 9(10):e1901875. PubMed ID: 32329247
[TBL] [Abstract][Full Text] [Related]
19. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.
Zhang JW; Chu YM; Lan ZM; Tang XL; Chen YT; Wang CF; Che X
World J Gastroenterol; 2015 Apr; 21(14):4255-60. PubMed ID: 25892876
[TBL] [Abstract][Full Text] [Related]
20. Aspirin use and the risk of cholangiocarcinoma.
Choi J; Ghoz HM; Peeraphatdit T; Baichoo E; Addissie BD; Harmsen WS; Therneau TM; Olson JE; Chaiteerakij R; Roberts LR
Hepatology; 2016 Sep; 64(3):785-96. PubMed ID: 26940227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
